FCCID.CO- FCC ID Database
HomeCompaniesEquipment ClassesSearch

© 2026 FCC ID Database. All rights reserved.

AboutContactData sourced from FCC public records
  1. Home/
  2. Andon Health Co., Ltd/
  3. ZRYBG5

ZRYBG5Part 15 Spread Spectrum Transmitter

Andon Health Co., Ltd
Part 15 Spread Spectrum Transmitter - FCC ID ZRYBG5 - Andon Health Co., Ltd
Click to zoom

Application Details

Equipment Class
DSS - Part 15 Spread Spectrum Transmitter
Date of Grant
Jan 28, 2013
Application Purpose
Original Equipment
Date of Application
Jan 26, 2013
Equipment Note
Part 15 Spread Spectrum Transmitter
Frequency Range
2402.00000000 - 2480.00000000
Company
Andon Health Co., Ltd
Country
China

Documents & Files

Select a file to view

Users Manual

↗

Cover Letter(s)

↗
↗

External Photos

↗

ID Label/Location Info

↗

Internal Photos

↗

RF Exposure Info

↗

Test Report

↗

Test Setup Photos

↗

Document Text

Text extracted from the exhibit documents filed with the FCC. Open a document above to read the original.

Users Manual

Page 1 of 27 For in vitro diagnostic use only Read instructions before use For self-testing iHealth TM Wireless Smart Gluco‐Monitoring System (BG5) OWNER’S MANUAL Table of Contents INTRODUCTIN ...............................................................................................................................2 PACKAGE CONTENTS.................................................................................................................2 SETUP REQUIREMENTS ............................................................................................................4 INTENDED USE .............................................................................................................................4 How the Test Works? .....................................................................................................................5 IMPORTANT SAFETY INSTRUCTIONS ....................................................................................5 IMPORTANT TESTING INFORMATION.....................................................................................6 INFORMATION ABOUT ALTERNATIVE SITE TESTING (AST) .............................................6 What is Alternate Site Testing?.................................................................................................7 What is the Advantage of Alternative Site Testing? .................................................................7 When to Use Alternative Site Testing? .....................................................................................7 PARTS AND DISPLAY INDICATORS .........................................................................................9 Glucose Meter...........................................................................................................................9 Blood Glucose Test Strip .........................................................................................................10 SETUP PROCEDURES ............................................................................................................ 11 TESTING WITH A BLOOD SAMPLE ........................................................................................12 Offline measurement mode(not using iOS device) .............................................................12 Apply the Test Strip ......................................................................................................... 12 Obtaining a Blood Sample ............................................................................................... 12 Apply Your Blood Sample ................................................................................................ 12 Read the Test Results ...................................................................................................... 12 Discard the Used Test Strips ............................................................................................ 12 Discard the Used Lancet .................................................................................................. 13 Online measurement mode(with iOS device) .....................................................................13 Apply the Test Strip ......................................................................................................... 13 Obtaining a Blood Sample ............................................................................................... 13 Apply Your Blood Sample ................................................................................................ 13 Read the Test Results ...................................................................................................... 14 Discard the Used Test Strips ............................................................................................ 14 Discard the Used Lancet .................................................................................................. 14 Control Solution ............................................................................................................................14 Page 2 of 27 Performing an Offline Control Solution Test with Meter Alone (not using iOS device) ........15 I Performing an Online Control Solution Test (with iOS device) ...........................................16 IMPORTANT INFORMATION ABOUT CONTROL SOLUTION TESTS...............................17 METER MEMORY ........................................................................................................................17 Offline measurement mode(not using iOS device) .............................................................17 Reviewing Test Results .................................................................................................... 17 Online measurement mode(with iOS device) .....................................................................18 REFERENCE VALUE OF THE IHEALTH WIRELESS SMART GLUCOSE METER.........18 COMPARING GLUCOSE METER TEST RESULTS WITH LABORATORY RESULTS ....18 Before Going to the Lab .........................................................................................................19 While at the Lab......................................................................................................................19 Cleaning and Disinfection...............................................................................................................19 IHEALTH WIRELESS SMART GLUCO-MONITORING SYSTEM SPECIFICATIONS......21 Maintenance and Storage of your Wireless SMART GLUCOSE METER...........................21 LIMITATIONS OF USE ................................................................................................................22 SYSTEM TROUBLE SHOOTING ..............................................................................................23 Result Readings ......................................................................................................................23 Error Message ............


Text truncated - open the document above for the full version.

External Photos

PrÃŒfbericht - Nr.: Test Report No.: 15058197 001 1. Photographs of EUT Photograph 1: PrÃŒfbericht - Nr.: Test Report No.: 15058197 001

Internal Photos

PrÃŒfbericht - Nr.: Test Report No.: 15058197 001 1. Photographs of EUT Photograph 1: PrÃŒfbericht - Nr.: Test Report No.: 15058197 001 Photograph 2:

RF Exposure Info

Produkte Products RF Exposure Statement: Page 1 of 1 Client: ANDON HEALTH CO.,LTD No. 3 Jinping Road, Ya An Street Nankai District Tianjin P.R. China Test item: iHealth Wireless Smart Gluco-Monitoring System Identification: BG5 FCC ID : ZRYBG5 FCC Requirement According to FCC 2.1091, mobile equipment must comply with the following applicable limit for maximum permissible exposure (MPE) specified in FCC 1.1310: Equipment Use Frequency Range Power Density [mW/cm 2 ] Average Time [min] General Population / Uncontrolled Exposure 1.5 – 100GHz 1 6 IC Requirement According to RSS-102 (Issue 4), clause 2.5.2, no routine RF exposure evaluation is required if the transmitter power (e.i.r.p.) is below the following threshold: Frequency Range SAR Limitation [W] Above 1.5GHz 5 Measurement Result The maximum measured transmitter power is the following: Conducted Output Power P out [mW] Maximum Antenna Gain [dBi] P out EIRP [mW] Power Density at 20cm [mW/cm 2 ] 1.05 2.45 0.24 55 0.00036 Note: The power density S in mW/cm 2 is calculated according to the Friis formula: S = (P S = power density in mW/cm 2 P out = antenna conducted output power in mW G = antenna gain in linear scale (here: 2.45dBi=10log(G)) D = distance between observation point and radiating structure in cm (here: 20cm) out · G) / (4π · D 2 ), where Conclusion The device complies with the FCC and IC RF exposure requirements since the maximum transmitter power density is below the FCC limit and the e.i.r.p. power is below the IC RF exposure evaluation exemption threshold. Refer to test repo rt 15058197 001 for more details. TÜV Rheinland (Shanghai) Co., Ltd. 10-15/F, Huatsing Building, No.88, Lane 777, Guangzhong Road West, Shanghai 200072, P.R. China

Test Report

✁ ✂ ✄☎ ✆ ✝✞ ✟✠✡☛☞ ✌ ✍ ✎ ✏ ✑✒✓✔✑✕✖✗✓✘ ✖✙✚ ✛ ✜ ✢ ✣ ✜✀✥✊✧★ ✩ ✪ ✫✬✑✭✖ ✮✯✰ ✱✲✳✎✵✶✶✷✞✹✺✶✻✶✌✳✜✶ ✔ ✟✿❀ ❁✏ ✚ ✪ ❂❃❃ ✌✳✶✌✌✎✶✷✞✹ ✺✶✻✶✌✳✜✎✌❄✶✌ ✔ ✟✿❀ ❁✏ ✚ ✪ ❂❃❃ ✱✌❄✞❅✳✶❄✞✳❆✞✳✱❇✶✺❈✎✌❄ ✔ ✟✿❀ ❁✏ ✚ ✪ ❂❃❃ ✎✺✺✹ ✶✺✺✶✷✞✶✌❅❉✶❆✎✺✎✳✹✱✌✎✎✌❄❈ ✔ ✟✿❀ ❁✏ ✚ ✪ ❂❃❃ ❄✎✌❄❇✹ ❄✳❊✎✎✌❄✎ ✎✌❄❇✹ ❄✳❊✶✌ ✞✻❈✶✺✱❋✱❆❆✹ ✌✵✺✶✷✞✶✌❅✹ ✶✜✎✹✹✹✎✌❄❄ ✔ ✟✿❀ ❁✏ ✚ ✪ ❂❃❃ ●✶✺✎✵✶✹✻✶✱❋❅❅✞❆✎✌❅❉✎✹ ✹ ✹✎✌❄❄ ✔ ✟✿❀ ❁✏ ✚ ✪ ❂❃❃ ✱✌❄✞❅✳✶❄❆✞✺✹✱✞✜✻✹✜✜✹✱✌❄✎✌❄ ✔ ✟✿❀ ❁✏ ✚ ✪ ❂❃❃ ✎✌❄❄✵✶✱✻❆✲✹✎✌❅✶✱❋✱✌❄✞❅✳✶❄✻✹✜✜✹✱✌❄✎✌❄ ✔ ✟✿❀ ❁✏ ✚ ✪ ❂❃❃ ✎✌❄❄✵✶✎❄✹✎✳✶❄✻✹✜✜✹✱✌❄ ✎✌❄ ✔ ✟✿❀ ❁✏ ✚ ✪ ✫✒✒ ✎❄✹✎✳✶❄❆✞✺✹✱✞✜✻✹✜✜✹✱✌✱❋✺✎✌✜✻✹✳✳✶✺ ❄✎✌❄ ✔ ✟✿❀ ❁✏ ✚ ✪ ❂❃❃ ✎❄✹✎✳✶❄❆✞✺✹✱✞✜✻✹✜✜✹✱✌✱❋✶❅✶✹●✶✺ ✶✌ ✔ ✟✿❀ ❁✏ ✚ ✪ ❂❃❃ ✱❇✶✺✹ ✌✶✱✌❄✞❅✳✶❄✻✹✜✜✹✱✌✎✌❄✶✌ ✔ ✟✿❀ ❁✏ ✚ ✪ ❂❃❃ ✁ ✂ ✄☎ ✆ ✝✞ ✟✠✡☛☞ ✌ ✍ ✎ ✏ ✑✒✓✔✑✕✖✗✓✘ ✖✙✚ ✛ ✜ ✢ ✣ ✜❍✥✊✧★ ✩ ✪ ✫✬✑■✖ ✮✯✰ ✶✌✶✺✎✲✶✻✎✺❏✜ ✱✻❆✲✶✻✶✌✳✎✺❉✎✳✶✺✹✎✲✜ ✶✜✳✹✳✶✜ ✶✜✳✎❅✹ ✲✹✳✹ ✶✜ ✹✜✳✱❋✶✜✳✎✌❄✶✎✜✞✺✶✻✶✌✳✌✜✳✺✞✻✶✌✳✜ ✶✎✜✞✺✶✻✶✌✳✌❅✶✺✳✎✹ ✌✳❉ ✶✌✶✺✎✲✺✱❄✞❅✳✌❋✱✺✻✎✳✹✱✌ ✺✱❄✞❅✳✞✌❅✳✹✱✌✎✌❄✌✳✶✌❄✶❄✜✶ ❉✜✳✶✻✶✳✎✹ ✲✜ ■✙✭✙ ❑▲ ✖▌✓✫✬✑✔ ✑◆❖ c ✗✑◗✑❘✓✒ ❙❚❯❯ ❑✯ ✙■ ❑❱ ✑ ❲ ✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙❳ ■✙✭✙✭❚❘✓✑❘❘✫✔ ✑◆❖ c ✗✑◗✑❘✓✒ ❙❚❯❯ ❑✯ ✙✭ ✰ ■ ❙❚❯ ❯ ❑✯ ✙✭ ✰ ❩ ✫❘❬✔✿✿ ❭❪ ✑❘❳✙ ❑ ✙ ❩ ✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙❫ ✌❄✶❆✶✌❄✶✌✳❆✶✺✎✳✹✱✌✱❄✶✜ ✲✱❅❏✺✶✷✞✶✌❅✹ ✶✜ ✱✹✜✶✞❆❆✺✶✜✜✹ ✌✵✎✺✳✜ ✶✜✳✶✳✞❆✎✌❄❆✶✺✎✳✹✱✌✱❄✶✜ ✶✜✳✶✳❊✱❄✱✲✱✵❉ ❊❉✜✹❅✎✲✱✌❋✹✵✞✺✎✳✹✱✌❋✱✺✶✜✳✹ ✌✵ ✶✜✳❆✶✺✎✳✹✱✌✎✌❄✶✜✳✱❋✳❇✎✺✶ ❆✶❅✹✎✲❅❅✶✜✜✱✺✹ ✶✜✎✌❄✞❎✹ ✲✹✎✺❉✷✞✹ ❆✻✶✌✳ ✱✞✌✳✶✺✻✶✎✜✞✺✶✜✳✱✎❅❊✹ ✶●✶✱✻❆✲✹✎✌❅✶ ✶✜✳✶✜✞✲✳✜✱❋✱✌❄✞❅✳✶❄✶✎✜✞✺✶✻✶✌✳✜✎✳✌✳✶✌✌✎✱✺✳ ✺✎✌✜✻✹✳✳✶✺✎✺✎✻✶✳✶✺✜ ✯ ✙ ❑ ✙ ❑ ❯ ✖❘❬❖❵✓✑❬❛❖✓✕❖✓ ✪ ✖❜✑✗ ❙❚❯ ❯ ❑✯ ✙✭ ❩ ❳ ❱ ❝ ❲❱❑❲ ✫❘❬✔✿✿ ❭ ✭ ❑✰ ❚❫✙ ❩ ❱ ✭ ❲ ✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙ ❑✰ ✯ ✙ ❑ ✙✭ ❯ ✫✗✗ c ✑✗ ❚ ✗✑◆❖✑❘❵ ❞ ✿✑✕✫✗✫✓ c ✖❘ ❙❚❯ ❯ ❑✯ ✙✭ ❩ ❳ ❱ ✫ ❲❱❑❲ ✫❘❬✔✿✿ ❭ ✭ ❑✰ ❚❫✙ ❑❱ ❝ ❲ ✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙ ❑ ✭ ✯ ✙ ❑ ✙■✭ ✰ ❬ ❡❡ ✫❘❬❜ c ❬✓ ❢ ❙❚❯ ❯ ❑✯ ✙✭ ❩ ❳ ❱ ✫ ❲❱❑❲ ✫❘❬✔✿✿ ❭ ✭ ❑✰ ❚❫✙ ❑❱ ✫ ❲ ✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙ ❑✯ ✯ ✙ ❑ ✙ ❩❣❣ ❀ ❡ ✫❘❬❜ c ❬✓ ❢ ❙ ✔✿✿ ❭❪ ✑❘ ❩ ✙✐✙ ❑ ✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙ ❑ ❣ ✯ ✙ ❑ ✙ ✯ ✘❖◗ ❝ ✑✗✖ ✮❥ ✖✕✕ c ❘✬ ❚ ✗✑◆❖✑❘❵ c ✑✒ ❙❚❯❯ ❑✯ ✙✭ ❩ ❳ ❱ ✫ ❲❱❑❲❱ ccc ❲ ✫❘❬✔✿✿ ❭ ✭ ❑✰ ❚❫✙ ❑❱ ❬ ❲ ✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✭■ ✯ ✙ ❑ ✙✐❚❊✑✗✫✬✑ ✏c ◗✑✖ ✮ ❛❵❵❖✕✫❘❵ ❞ ❙❚❯ ❯ ❑✯ ✙✭ ❩ ❳ ❱ ✫ ❲❱❑❲❱ ccc ❲ ✫❘❬✔✿✿ ❭ ✭ ❑✰ ❚❫✙ ❑❱ ❬ ❲ ✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✭✐ ✯ ✙ ❑ ✙❳ ❯ ✖❘❬❖❵✓✑❬✿✕❖✗ c ✖❖✒✟◗ c ✒✒ c ✖❘ ❙❚❯ ❯ ❑✯ ✙✭ ❩ ❳ ❱ ❬ ❲ ✫❘❬✔✿✿ ❭ ✭ ❑✰ ❚❫✙ ✯ ✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✭ ❣ ✯ ✙ ❑ ✙❫ ❡ ✫❘❬✟❬✬✑ ❯ ✖◗✕▌ c ✫❘❵✑✖ ✮ ✔ ❚❯ ✖❘❬❖❵✓✑❬✟◗ c ✒✒ c ✖❘ ❙❚❯❯ ❑✯ ✙✭ ❩ ❳ ❱ ❬ ❲ ✫❘❬✔✿✿ ❭ ✭ ❑✰ ❚❫✙ ✯ ✙✙✙✙✙✙✙✙■ ✯ ✶✜✳✶✜✞✲✳✜✱❋✎❄✹✎✳✶❄✶✎✜✞✺✶✻✶✌✳✜ ✺✎✌✜✻✹✳✳✶✺✎✺✎✻✶✳✶✺✜ ✐✙ ❑ ✙ ❑ ❡ ✫❘❬✟❬✬✑✔ ✫❬ c ✫✓✑❬✟◗ c ✒✒ c ✖❘ ❙❚❯ ❯ ❑✯ ✙✭ ✰✯ ❙❚❯ ❯ ❑✯ ✙✭ ✰ ❣ ❙❚❯ ❯ ❑✯ ✙✭ ❩ ❳ ❱ ❬ ❲ ❙ ✔✿✿ ❭ ✭ ❑✰ ✭✙✭ ❙ ✔✿✿ ❭ ✭ ❑✰ ✭✙✐✫❘❬✔✿✿ ❭ ✭ ❑✰ ❚❫✙ ✯ ✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙■❫ ✐✙ ❑ ✙✭✔✫❬ c ✫✓✑❬✿✕❖✗ c ✖❖✒✟◗ c ✒✒ c ✖❘✖ ✮ ✏ ✗✫❘✒◗ c ✓✓✑✗ ❙❚❯ ❯ ❑✯ ✙✭ ✰✯ ❙❚❯ ❯ ❑✯ ✙✭ ✰ ❣ ❙❚❯ ❯ ❑✯ ✙✭ ❩ ❳ ❱ ❬ ❲ ❙ ✔✿✿ ❭ ✭ ❑✰ ✭✙✭ ❙ ✔✿✿ ❭ ✭ ❑✰ ✭✙✐✫❘❬✔✿✿ ❭ ✭ ❑✰ ❚❫✙ ✯ ✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙ ❩❩ ✁ ✂ ✄☎ ✆ ✝✞ ✟✠✡☛☞ ✌ ✍ ✎ ✏ ✑✒✓✔✑✕✖✗✓✘ ✖✙✚ ✛ ✜ ✢ ✣ ✜❧✥✊✧★ ✩ ✪ ✫✬✑ ❩ ✖ ✮✯✰ ✶❅✶✹●✶✺✎✺✎✻✶✳✶✺✜ ✐✙✭✙ ❑ ✔✫❬ Y ✫✓✑❬✿✕❖✗ Y ✖❖✒✟◗ Y ✒✒ Y ✖❘✖ ✮ ✔✑❵✑ Y ❩✑✗ ❙❚❯❯ ❑✯ ✙ ❑✰ ❣ ❙ ✔✿✿ ❭ ✭ ❑✰ ✭✙✭ ❙ ✔✿✿ ❭ ✭ ❑✰ ✭✙✐ ❙ ✔✿✿ ❭ ✭ ❑✰ ❚❫✙ ✯ ❙ ✔✿✿ ❭❪ ✑❘❳✙✭✙■✙✭✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙ ❩ ✐ ✶✜✳✶✜✞✲✳✜✱❋✱❇✶✺✹ ✌✶✱✌❄✞❅✳✶❄✶✎✜✞✺✶✻✶✌✳✜ ✐✙■✙ ❑ ❚ ❯ ✪ ✖❜✑✗ ❁Y ❘✑ ❯ ✖❘❬❖❵✓✑❬✟◗ Y ✒✒ Y ✖❘ ❙❚❯❯ ❑✯ ✙✭ ✰ ❳✫❘❬✔✿✿ ❭❪ ✑❘❳✙✭✙✭✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙✙ ❩ ❳ ❊✱✳✱✵✺✎❆❊✜✱❋✳❊✶✶✜✳✶✳✞❆ ✹✜✳✱❋✎❈✲✶✜ ✹✜✳✱❋✹✵✞✺✶✜ ✹✜✳✱❋❊✱✳✱✵✺✎❆❊✜ ✁ ✂ ✄☎ ✆ ✝✞ ✟✠✡☛☞ ✌ ✍ ✎ ✏ ✑✒✓✔✑✕✖✗✓✘ ✖✙✚ ✛ ✜ ✢ ✣ ✜★✥✊✧★ ✩ ✪ ✫✬✑ ✯ ✖ ✮✯✰ ♠♥♥♊♣ ♣ ♩NOP Q✉ ♣ ✈ ♩✇ Q①✉ ♣ Q② ✇♊♥③♊✇♣ ✈④ â‘€ ♣O ①✈ ♣ Q✈ ♣✇ Q ③ ④ ✇♣⑥ ⑩⑧ ①Q ⑹ Q⑩ ⑹ Q NO ✉④ ♥ ④② ❶❷ ❾⑧ ❹ O ④ ⑧❺❻ ④ ⑥ ❌ ❜♣❟⑥ ❿ ④ ⑥➀➀➁ ④✉② ❶ Q➂ ➃⑥ ❾⑧ ❹ O ④ ⑧➄ ✉ ❟ ⑧ ✈ ♣ ✉ ♊♥➅♊✇ ⑩ ❜ ④ â‘§â‘€ Q✉② ➁ ① ➆ ⑹ Q NO➃ Q➇Q ♥ ④ ③P Q✉ ♣ ➈ ④✉Q ⑥ ❌ ❾⑧ ❹ O ④ ⑧ ❌ ❻ O ①✉ ♩ ⑹O Q ⑧ ✈Q ❟♣ Q✈ ♣ Q➉ ⑧ ① ③P Q✉ ♣ ①✈①✉ ♩NN ④ ✇❟♊ ✉ N Q➊① ♣O ❻➄ ❞ ➅ ➂➋ ➌ â‘€ ④ ✇P Q ♩ ✈ ⑧ ✇ Q P Q✉ ♣ ④ â‘€ ✇♊❟ ①④ ①✉ ♣ Q ✇ â‘€ Q ✇ Q✉ N Q ⑥ ⑹O Q➍Q ❟ Q ✇♊♥ ❻ ④ PP ⑧ ✉① N♊♣ ①④✉✈ ❻ ④ PP ①✈✈①④✉ O♩ ✈ ✇ Q➇①Q➊Q ❟♣O Q ♣ Q NO ✉① N♊♥NO♩✇♩N♣ Q ✇ ①✈ ♣ ① N ✈④ â‘€ ♣O Q ✇♊❟ ① ♊♣ Q ❟♊ ✉ ❟N ④✉ ❟ ⑧ N♣ Q ❟ Q P ①✈✈①④✉ â‘€ ♩N ① ♥ ① ♣ ❶ ❌♊ ✉ ❟O♩ ✈ â‘€ ④ ⑧ ✉ ❟♣O Q✈Q ♣ Q✈ ♣ â‘€ ♩N ① ♥ ① ♣ ①Q✈ ♣ ④➎Q①✉ N ④ P③♥ ① ♩ ✉ N Q➊① ♣O♣O Q ✇ Q➉ ⑧ ① ✇ Q P Q✉ ♣ ✈④ â‘€ ✈Q N♣ ①④✉➏ ⑥➀➐➑ ④ â‘€ ♣O Q➍ ❻❻ ✇ ⑧ ♥ Q✈ ⑥⑚O Q ❟ Q✈ N✇ ① ③♣ ①④✉④ â‘€ ♣O Q ♣ Q✈ ♣ â‘€ ♩N ① ♥ ① ♣ ❶ ①✈ ♥ ①✈ ♣ Q ❟ ⑧ ✉ ❟ Q ✇ ➍ ❻❻ ✇ Q②①✈ ♣✇♊♣ ①④✉✉ ⑧ P ➎Q ✇➑➒➒➓➀ ➏ ⑥ ⑹O Q ➄ ✉ ❟ ⑧ ✈ ♣✇ ❶ ❻ ♩ ✉ ♊❟♊O♩ ✈ ✇ Q➇①Q➊Q ❟♣O Q ♣ Q NO ✉① N♊♥NO♩✇♩N♣ Q ✇ ①✈ ♣ ① N ✈④ â‘€ ♣O Q ✇♊❟ ① ♊♣ Q ❟♊ ✉ ❟ N ④✉ ❟ ⑧ N♣ Q ❟ Q P ①✈✈①④✉ â‘€ ♩N ① ♥ ① ♣ ❶ ❌♊ ✉ ❟O♩ ✈ â‘€ ④ ⑧ ✉ ❟♣O Q✈Q ♣ Q✈ ♣ â‘€ ♩N ① ♥ ① ♣ ①Q✈ ♣ ④➎Q①✉ N ④ P③♥ ① ♩ ✉ N Q ⑥⑚O Q ❟ Q✈ N✇ ① ③♣ ①④✉④ â‘€ ♣O Q ♣ Q✈ ♣ â‘€ ♩N ① ♥ ① ♣ ❶ ①✈ ♥ ①✈ ♣ Q ❟ ⑧ ✉ ❟ Q ✇NO♩P ➎Q ✇ ✈ â‘€ ① ♥ ①✉②✉ ⑧ P ➎Q ✇➐➒➔ →➣ ⑥ ✁ ✂ ✄☎ ✆ ✝✞ ✟✠✡☛☞ ✌ ✍ ✎ ✏ ✑✒✓✔✑✕✖✗✓✘ ✖✙✚ ✛ ✜ ✢ ✣ ✜↔✥✊✧★ ✩ ✪ ✫✬✑✐✖ ✮✯✰ ↕➙ ➄ ⑹ P✈ ♣ ➂P T P①➇P ✇↕ ❞❻➄ ➋ ➒➒ → ➔➓ ➏ ➒ ➋ ➓⑥➒➐⑥ ➋ ➑ ❞ ③ P T♣✇ ⑧ e♠ ✉ ♊♥ ❶❹ P ✇❿➀➒ ➋ ➒♠➙➛➐➑➒➓➒➐➀➐ ➏ ➒ ➋ ➓⑥➒➐⑥ ➋ ➑ ➣ ① ♥ ④② ♠ ✉ ♣ P✉✉ ♩ ❻ ➣ ❜➌ ➋➋➏ ➃ ➏ ➔➌ ➋➋➏ ➒ ➋ ➓⑥ ➋ ➒⑥ ➋ → ➣ ✇ ④ ♊❟ ➆ ➣ ♩ ✉ ❟➁ ④ ✇ ✉ ♠ ✉ ♣ P✉✉ ♩ ➣➣ ➁♠➀ ➋➏ ➒➃➐➀➀ ➏ ➒ ➋ ➐⑥➒➌⑥➒➑ ➅✇ P ♩e③♥ ① â‘€ ①P ✇❿ ❞ ➅ ➋ ➑➒➒ ➆ ➏ → ➋ ➓➌➐ ➋ ➑ → ➏ ➒ ➋ ➓⑥➒ → ⑥➒➐ ❻ ④ ♩➜ ① ♊♥ ❻ ♩ ➎ ♥ P ❞➝❻➞ ➍ ❜↕➟ ➋ ➒➌♠ ❻ ➏ ➆ ❻ ➏ ➒ ➋ ➓⑥➒➓⑥➒ ➏ ⑹ P e③ P ✇♊♣ ⑧ ✇ P➠ ➁ ⑧ e ① ❟ ① ♣ ❶ ➙ P ♣ P ✇➈ ❻ ➋ ➆ ➏ ♠ ❻ ➏ ➆ ⑹➁ ➏ ➒ ➋ ➓⑥➒ ➋ ⑥ ➋ ➒ ❞ ③ P T♣✇ ⑧ e♠ ✉ ♊♥ ❶❹ P ✇ ➍ ❞ ➅➓➒ ➋ ➒➒ ➋ ➀ ➏➏ ➒ ➋ ➓⑥➒➔⑥ ➏➋ ➡ ➢➀➥➊➧➢➚ ➢➩ ➫➭ ➯➲ ➢➳➧➢➵➊➢➩➞ ➯➺ ➩➞➢➧ ➫ ➀➻➩ ➫ ➯ ➌➜ ➟ ➚ ➜➜ ➪➶➹➘ ➟➎ ➹ ➜➷ ➬ ➮ ➟ ➚ ➷➱ ✃❐❒❒❐➹ ➜❮❰ ¥Š § ̈© ª« ¬➷­ ® ❰ ¥Š § ̈© ª ̄ °➷­ ± ➪ ➷ ❐➪ ➟ ➚ ➷➱ ✃❐❒❒❐➹ ➜ « © ² Š §³ ❰ ¥Š § ̈ ́ ª« Ό➷­ ® ❰ ¥Š § ̈ ́ ª ÎŒ © ➷­ ✁ ✂ ✄☎ ✆ ✝✞ ✟✠✡☛☞ ✌ ✍ ✎ ✏ ✑✒✓✔✑✕✖✗✓✘ ✖✙✚ ✛ ✜ ✢ ✣ ✜?✥✊✧★ ✩ ✪ ✫✬✑❳✖ ✮✯✰ ⑹M N ↕ ➝ ⑹ ❷ ↕ ➉ ⑧ ① ③V N✉ ♣ ➝ ✉ ❟ N ✇⑹ N✈ ♣ ❺ ①✈ ♩ ➣ ♥ ⑧ N ♣ ④④ ♣MV ④ ❟ ⑧ ♥ N ⑥ ➂ ♊❟ ①④✈ ♣♊ ✉ ❟♊✇❟c ➣ ♥ ⑧ N ♣ ④④ ♣M ❞ ③ N e ① â‘€ ①N ❟ ④ ⑧ ♣③ ⑧ ♣③ ④➊N ✇c➒⑥ ➏➋ ❟ ➣ V ♠ ✉ ♣ N✉✉ ♩ ② ♩ ①✉ c ➏ ⑥➐ → ❟ ➣ ① ♠ ✉ ♣ N✉✉ ♊♣ ❶ ③ N c ➄ ✉ ♣ N ✇ ✉ ♊♥♊ ✉ ♣ N✉✉ ♩ ♠ ✉ ♣ N✉✉ ♩V ④ ⑧ ✉ ♣ ①✉② ♣ ❶ ③ N c➅✇ ①✉ ♣ N ❟ ♠ ✉ ♣ N✉✉ ♩e♩ ➎ ♥ N ♥ N✉② ♣M


Text truncated - open the document above for the full version.

Test Setup Photos

PrÃŒfbericht - Nr.: Test Report No.: 15058197 001 1. Photographs of the Test Setup Photograph 1: Set-up for Radiated Emission, 30MHz-1000MHz PrÃŒfbericht - Nr.: Test Report No.: 15058197 001 Photograph 2: Set-up for Radiated Emission, 1G-18GHz Photograph 3: Set-up for Conduct Power

Contact Information

Applicant

Ming Cong(PM)
[email protected]+86-22-60526161Fax: +86-22-60526162

Technical Contact

TᅵV Rheinland (Shanghai) Co., Ltd
[email protected]

China

Test Firm

TUV Rheinland (Shanghai) Co., Ltd.Xinhua LU
[email protected](86-21)33034599Fax: (86-21)63542366

Technical Specifications

#Rule PartsFrequency RangePower Output
115C2.40 GHz - 2.48 GHz1.00 mW
Confidentiality
Long Term
Grant Notes
Output power listed is peak conducted.

Other Applications from Andon Health Co., Ltd

Blood Pressure Monitor - FCC ID ZRY557BT - Andon Health Co., Ltd
ZRY557BT

Blood Pressure Monitor

Jul 03, 2014

Equipment Class

DSS - Part 15 Spread Spectrum Transmitter
Blood Glucose Meter - FCC ID ZRYGMM0001 - Andon Health Co., Ltd
ZRYGMM0001

Blood Glucose Meter

Jul 11, 2013

Equipment Class

DSS - Part 15 Spread Spectrum Transmitter
iHealth Wireless Smart Gluco-Monitoring System - FCC ID ZRYBG5L - Andon Health Co., Ltd
ZRYBG5L

iHealth Wireless Smart Gluco-Monitoring System

Jun 09, 2013

Equipment Class

DTS - Digital Transmission System
iHealth Pulse Oximeter - FCC ID ZRYPO3 - Andon Health Co., Ltd
ZRYPO3

iHealth Pulse Oximeter

Mar 30, 2013

Equipment Class

DTS - Digital Transmission System
Activity Monitor - FCC ID ZRYAM3 - Andon Health Co., Ltd
ZRYAM3

Activity Monitor

Mar 30, 2013

Equipment Class

DTS - Digital Transmission System